Blood test could revolutionize esophageal cancer care

NCT ID NCT05704530

Recruiting now Knowledge-focused Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 03, 2026 · Last updated Jun 14, 2026 · Updated 3 times

Summary

This study looks at whether a blood test that detects tiny bits of tumor DNA can help doctors better stage esophageal cancer and predict if it will come back after treatment. About 248 adults with resectable esophageal cancer will give blood samples before, during, and after their standard care. The goal is to see if this test can guide more personalized treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AZ Delta
RECRUITING

Roeselare, Belgium

Contact

Contact
UZ Gent
RECRUITING

Ghent, Belgium

Contact
UZA
RECRUITING

Antwerp, Belgium

Contact
UZLeuven
RECRUITING

Leuven, Belgium

Contact

Contact

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL CANCER